Search results
Weakening sense of smell is linked to heart failure risk in a new study
MedicalNewsToday via AOL· 5 days agoWright was also not involved in the research. He told us he found the prognostic potential of...
Maternal history of Alzheimer’s may be the most important to genetic risk
MedicalNewsToday via AOL· 2 days agoA history of Alzheimer's disease on the mother's side might be more important in determining a...
Study finds one copy of protective genetic variant helps stave off early-onset Alzheimer's disease
Science Daily· 5 days agoThe study, published in The New England Journal of Medicine, represents the first evidence that having one copy of the Christchurch... we must leverage this new knowledge ...
Intelligent Bio begins dosing for non-invasive drug screening technology
Clinical Trials Arena via Yahoo Finance· 5 days agoThe PK study aims to investigate the levels of opiates in fingerprint sweat compared with blood,...
UGA-developed nasal COVID-19 vaccine heading to clinical trials
WAGA fox local articles via Yahoo News· 4 days ago(Photo credit: Andrew Davis Tucker/UGA) "We are very excited about this opportunity to test a novel...
'Exciting' new Parkinson's treatment may cure root cause
Newsweek· 4 days agoAn "exciting" new Parkinson's disease drug promises to not only treat but to cure the condition at...
A simple blood test may soon allow diagnoses of early-stage Parkinson’s disease
Courthouse News Service· 6 days agoThe study authors say that a blood test for a specific panel of proteins can be used to predict the...
Annovis Bio (NYSE: ANVS) Officials to Present Results from Alzheimer's Study at AAIC 2024
Digital Journal· 3 days agoHe will be joined by Kathleen ... founder and president. Titled "Data from Phase 2/3 Clinical Study in Mild to Moderate Alzheimer's ...
Could a genetic trait delay Alzheimer's?
USA TODAY via Yahoo News· 4 days agoYakeel T. Quiroz, a study co-author and clinical neuropsychologist and neuroimaging researcher at Massachusetts General Hospital...Harvard Medical School ...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 5 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study< ...
